Anagenics Share Price and Company Fundamentals



Price
$0.035
Change
0.002 (6.061%)
52 week
0.019 - 0.067

Last traded: Today at 4:54 AM

Anagenics Limited operates as a health and beauty-tech company in Australia, New Zealand, Japan, and internationally. The company develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. It markets its products through various channels, including e-commerce, television shopping, wholesale pharmacy and salons, and cross border export markets. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

0.93

Dividend yield

0.00%

Beta

-0.67

Market cap

-

Enterprise value

-

Company profile

Primary activitiesHealth and beauty-tech business.
Industry / SectorBiotechnology / Healthcare
Websitehttps://anagenics.com
Mailing address55 Clarence Street Suite 204 Level 2 Sydney NSW 2000 Australia
Phone / Fax61 2 9221 6830 / 61 2 9221 8535
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Anagenics Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Anagenics paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AN1 dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

AN1's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Oct 2022, following are the company executives and directors listed on Anagenics.

NameTitleAgeTotal Pay
Mr. Matthew DudekActing Chief Exec. Officer636.27k
Mr. Dominic BurgChief Operating Officer
Ms. Carolyn HeathChief Customer Officer & GM of Sales
Dr. Graham RobertsonHead of R&D
Scott Mitchell GreasleyExec. Director
Mr. Lee Tamplin B.A.Company Sec.

Profitability and management effectiveness

Profit margin

-39.51%

Operating margin

-37.03%

Return on assets

-16.30%

Return on equity

-38.97%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Anagenics is and its enterprise value is .

Companies similar to Anagenics (AN1)

Anagenics (ASX:AN1) Frequently Asked Questions

1. What is Anagenics's Stock Symbol?

Anagenics trades on ASX under the ticker symbol "AN1".

2. What is Anagenics's stock price today?

One share of AN1 stock can currently be purchased for approximately $0.035.

3. How can I contact Anagenics?

Anagenics's mailing address is 55 Clarence Street Suite 204 Level 2 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9221 6830.

4. What is Anagenics's official website?

The official website of Anagenics is https://anagenics.com.

5. Which share registry manages Anagenics's stock?

Anagenics's stock is managed by AUTOMIC REGISTRY SERVICES.